The Oncology Institute, Inc. (NASDAQ:TOI) Sees Significant Increase in Short Interest

The Oncology Institute, Inc. (NASDAQ:TOI) saw a large increase in short interest in the month of February. As of February 15th, there was short interest totalling 934,800 shares, an increase of 188.3% from the January 31st total of 324,300 shares. Approximately 2.5% of the shares of the company are short sold. Based on an average daily trading volume, of 1,970,000 shares, the short-interest ratio is currently 0.5 days.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in TOI. Tiff Advisory Services LLC lifted its holdings in shares of Oncology Institute by 13.2% in the fourth quarter. Tiff Advisory Services LLC now owns 2,979,141 shares of the company’s stock worth $921,000 after buying an additional 346,256 shares in the last quarter. FreeGulliver LLC increased its holdings in shares of Oncology Institute by 219.3% in the fourth quarter. FreeGulliver LLC now owns 600,747 shares of the company’s stock worth $186,000 after purchasing an additional 412,578 shares during the period. Renaissance Technologies LLC increased its holdings in shares of Oncology Institute by 7.1% in the fourth quarter. Renaissance Technologies LLC now owns 182,000 shares of the company’s stock worth $56,000 after purchasing an additional 12,000 shares during the period. Virtu Financial LLC bought a new stake in Oncology Institute during the fourth quarter valued at $41,000. Finally, Jane Street Group LLC grew its position in Oncology Institute by 613.6% during the fourth quarter. Jane Street Group LLC now owns 127,659 shares of the company’s stock worth $39,000 after buying an additional 109,769 shares in the last quarter. Institutional investors own 36.86% of the company’s stock.

Oncology Institute Stock Performance

Shares of NASDAQ:TOI traded down $0.04 during trading on Friday, hitting $0.85. 301,543 shares of the company were exchanged, compared to its average volume of 870,819. The company has a market cap of $64.38 million, a PE ratio of -1.09 and a beta of 0.37. Oncology Institute has a 52-week low of $0.13 and a 52-week high of $2.10. The company has a debt-to-equity ratio of 5.91, a current ratio of 2.49 and a quick ratio of 2.27. The stock has a 50 day moving average of $0.65 and a 200 day moving average of $0.41.

Oncology Institute Company Profile

The Oncology Institute, Inc, an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services.